P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

February 2012

Features

Editorial

When One Size Doesn’t Fit All

CPOE systems should be smarter. Local customization of individual medication-related alerts is a good place to start.
Karl A. Matuszewski, MS, PharmD

Commentary

The FDA’s Social Media Guidelines Are Here … Were They Worth the Wait?

The FDA has delivered its highly anticipated guidelines for industry on how to respond to unsolicited requests (via social media platforms) for off-label information about prescription drugs and medical devices. The reviews have been mixed.
Miriam Reisman

Cost Analysis Before and After Implementation of a Computerized Physician Order Entry Order Form for Enoxaparin

The authors set out to determine whether a computerized physician order entry (CPOE) order form for enoxaparin would result in a lower cost of drug therapy per day if patients were switched to once-daily administration. Use of the CPOE enoxaparin order form did not reduce the daily cost of therapy, although cost savings did result when the hospital’s protocol was followed.
Rebecca S. Pettit, PharmD, MBA, BCPS; Christopher R. Zimmerman, PharmD, BCPS; Cesar Alaniz, PharmD; and Michael P. Dorsch, PharmD, MS, BCPS

Meeting Highlights

34th Annual San Antonio Breast Cancer Symposium and 53rd American Society of Hematology Annual Meeting and Exposition

Walter Alexander

Departments

Prescription: Washington

Under Scrutiny: FDA’s REMS for Opioids

Acceptance or Rejection by Stakeholders Will Influence Congress

Some say that the FDA’s proposed REMS opioids initiative does not go far enough to protect patients.
Stephen Barlas

Medication Errors

Misprogramming Patient-Controlled Analgesia Levels Causes Dosing Errors

Misprogramming pump levels of patient-controlled analgesia can lead to dosing errors.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Advate to prevent bleeding; Edarbi and Edarbyclor for hypertension; and Anturol gel for overactive bladder
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Indacaterol (Arcapta Neohaler) for Chronic Obstructive Pulmonary Disease

Arcapta Neohaler for chronic obstructive pulmonary disease
Rachel M. Slaton, PharmD, BCPS; and Danielle L. Cruthirds, PhD